Molo secures £266m in debt and equity funding led by Macquarie Group and Patron Capital
The investment will fund rapid growth in the UK mortgage market and further development of proprietary technology.
Molo is a digital mortgage lender providing online buy-to-let loans using automated decisioning and a proprietary platform. The company launched in late 2018 to streamline the property finance process for consumers.
Digital mortgage lender Molo has secured £266m in a combined debt and equity financing round to accelerate its expansion across the UK market. The investment was led by Macquarie Group and Patron Capital, with additional backing from international venture capital firm Yabeo and existing shareholders including Andenes Investments and GPS Ventures.
The new capital will be deployed toward scaling the company's online lending operations and further developing its proprietary technology stack. The raise follows a period of heightened demand for digital property finance following the COVID-19 pandemic, with application pipelines exceeding previous volumes.
From the founder
"Molo has reimagined the whole mortgage experience from scratch; we are applying the convenience and speed of today’s technology for today’s customers. Leveraging instant decisioning and real time data validation, customers can get certainty about their mortgage directly on their mobile, in minutes rather than weeks. This additional backing is a sign of trust in Molo, and we are proud to have reputable players like Macquarie, Patron and Yabeo on our team as we seek to revolutionize the mortgage market."
Francesca Carlesi
CEO and Co-Founder at Molo
Investor perspective
"The mortgage markets globally and particularly in the UK, are the largest financial services segments. Dominated still by traditional banking incumbents and brokerage set-ups, the market is ready for accelerated disruption, unlocking significant cost efficiencies and enabling consumer friendly online mortgage solutions. Molo is best equipped to spearhead these developments in the UK."
Gerrit Seidel
MD, Yabeo
Use of funds
- 01Continue product development
